AFK “System” has got a controlling stake in the “Synthesis”
Sistema increased its stake in Kurgan the manufacturer of medicines “Synthesis” to 56.2%, write “Vedomosti”. According to the representative of the Corporation, of shares were repurchased from the minority shareholders.
“Synthesis” is one of the largest pharmaceutical manufacturers of Russia, it produces antibiotics, drugs for the treatment of respiratory diseases and diseases of the musculoskeletal system. At the end of the first quarter of 2020 from AFK “System” was 46,51% of shares of “Synthesis” of 32.39% on “national immunobiological company” (“rostec”).
AFK Sistema is considering the possibility of merging their packages in the pharmaceutical assets of a holding company, confirmed the “Vedomosti” representative of the Corporation.
